The cough assist device is used with patients who are present with respiratory compromise and restricted lung patterns. These devices with the help of facemask, mouthpiece, or tracheostomy deliver gradual positive air pressure to the airway.
Market Dynamics
Substantial increase in number of patients suffering from chronic breathing disorder and rapid technological advancements in medical devices are major factors expected to drive the growth of global cough assisted devices market. Currently more than 25 million people in the United States have asthma. Approximately 14.8 million adults have been diagnosed with COPD, and approximately 12 million people have not yet been diagnosed. Product advancement activities by major players are approach towards introduction of innovative solutions are factors expected to impact the growth of target market.
In 2020, ABM Respiratory Care, a healthcare service provider, received clearance from the U.S. FDA for its first product, an airway clearance system known as “Biwaze Cough”. The portable device helps to remove secretions for people who are unable to cough or clear away secretions effectively on their own due to injury or disease.
In 2017, Ventec Life Systems, a medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for “VOCSN”. The product is portable life support device to combine five respiratory therapies such as Ventilation, Oxygen, Cough, Suction, and Nebulization (VOCSN, pronounced VOX-SEN).
High investment by major players are product innovation and business development activities in order to enhance the customer base and increase the revenue share is expected to augment the growth of cough assisted devices market. In 2020, Hillrom, a medical device company, launched two new respiratory therapy devices: the Volara™ System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara™ Cough System. This product launch is expected to help the company to enhance the product portfolio and increase the customer base. Favorable business policies by the government of developing countries and players focus on establishing new enterprises in emerging economies due to easy availability of raw material and low cost labor are factors expected to boost the target market growth. Rising pandemic effect across the globe and increasing demand for hospitals and clinics for breathing assistive device is expected to impact the growth of cough assisted devices market. More than 100 million Covid-19 cases have now been recorded worldwide. The United States passed 25 million confirmed cases and the largest death toll of over 420,000. Factors such as high cost of devices and stringent government regulations related to product approval are expected to hamper the growth of global cough assisted devices market. In addition, an incidence of product recall is expected to limit the adoption of devices further challenging the growth of target market. However, high investment by major players and introduction of more advanced products are factors expected to create new opportunities for players operating in cough assisted devices market over the forecast period. In addition, increasing focus on integration of AI in medical devices is expected to support the revenue transaction of target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global cough assisted devices market due to high patient pool suffering from asthma. Presence of large number of players operating in the country and introduction of innovative solutions in order to attract new customers is expected to support the growth of cough assisted devices market. In addition, increasing acquisition activities by major players in order to increase the business revenue share is expected to impact the regional market growth.
The market in Asia Pacific is expected to witness faster growth in the target market due to changing government regulations related to healthcare sector. In addition, favorable business policies and players approach towards emerging economies in order to track the untapped market are factor expected to support the regional market growth.
Competitive Landscape
The global cough assisted devices market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Cough Assisted Devices Market Segment Analysis, 2019
The global cough assisted devices market is segmented into product type, delivery type, and end use. The product type segment is bifurcated into automatic cough assist device and manual cough assist device. Among product type the automatic cough assist device is expected to witness faster growth in the cough assisted devices market. The end use segment is divided into hospitals, home care settings, others. Among the end use segment, the hospitals segment is expected to account for major revenue share in the global market. The players profiled in the report are Koninklijke Philips N.V., Hillrom., Percussionaire Corp., Dima Italia Srl, United Hayek Industries Inc, Ventec Life Systems, Air Liquide Medical Systems, Viemed., West Care Medical, McKesson Medical-Surgical Inc., Aetna Inc., Dymedso, International Biophysics Corporation, PARI GmbH, and Monaghan Medical Corporation.
Market Segmentation
Market By Product Type
Automatic Cough Assist Device
Manual Cough Assist Device
Market By Delivery Type
Face Mask
Mouth Piece
Adapter
Market By End Use
Hospitals
Homecare Settings
Others
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
